Literature DB >> 24345439

Prostate cancer risk alleles are associated with prostate cancer volume and prostate size.

Daniel Reinhardt1, Brian T Helfand2, Phillip R Cooper1, Kimberly A Roehl1, William J Catalona1, Stacy Loeb3.   

Abstract

PURPOSE: Genome-wide association studies have identified an increasing number of single nucleotide polymorphisms associated with prostate cancer risk. Some of these genetic variants are also associated with serum prostate specific antigen levels and lower urinary tract symptoms, raising the question of whether they are truly prostate cancer biomarkers or simply lead to detection bias. Therefore, we determined whether single nucleotide polymorphisms associated with prostate cancer risk are more strongly associated with tumor or prostate volume.
MATERIALS AND METHODS: The genotypes of 38 validated prostate cancer risk single nucleotide polymorphisms were determined in 1,321 white men who underwent radical prostatectomy. Univariate and multivariate analyses were performed to compare the relationship of single nucleotide polymorphism frequency with total prostate and tumor volumes.
RESULTS: On multivariate analysis 2 single nucleotide polymorphisms on chromosome 8q24, rs16901979 (A) and rs6983267 (G), were significantly associated with increased tumor volume (p=0.01 and 0.02, respectively). In contrast, rs17632542 (T) near the PSA gene on 19q13 was associated with significantly lower tumor volume and rs10788160 (A) on 10q26 was associated with significantly larger prostate volume (p=0.02 and 0.01, respectively).
CONCLUSIONS: Analysis of 38 single nucleotide polymorphisms associated with prostate cancer risk revealed a significant association between several on chromosome 8q24 and increased tumor volume but not prostate volume. This suggests that they are bona fide markers of prostate cancer susceptibility and possibly more aggressive disease. Other prostate cancer risk alleles are associated with prostate specific antigen and increased prostate or decreased tumor volume, suggesting detection bias due to their phenotypic influence.
Copyright © 2014 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  organ size; polymorphism; prostate; prostatic neoplasms; risk; single nucleotide

Mesh:

Substances:

Year:  2013        PMID: 24345439      PMCID: PMC4107200          DOI: 10.1016/j.juro.2013.12.030

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  29 in total

1.  8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.

Authors:  Nasim Ahmadiyeh; Mark M Pomerantz; Chiara Grisanzio; Paula Herman; Li Jia; Vanessa Almendro; Housheng Hansen He; Myles Brown; X Shirley Liu; Matt Davis; Jennifer L Caswell; Christine A Beckwith; Adam Hills; Laura Macconaill; Gerhard A Coetzee; Meredith M Regan; Matthew L Freedman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-07       Impact factor: 11.205

2.  Cumulative association of five genetic variants with prostate cancer.

Authors:  S Lilly Zheng; Jielin Sun; Fredrik Wiklund; Shelly Smith; Pär Stattin; Ge Li; Hans-Olov Adami; Fang-Chi Hsu; Yi Zhu; Katarina Bälter; A Karim Kader; Aubrey R Turner; Wennuan Liu; Eugene R Bleecker; Deborah A Meyers; David Duggan; John D Carpten; Bao-Li Chang; William B Isaacs; Jianfeng Xu; Henrik Grönberg
Journal:  N Engl J Med       Date:  2008-01-16       Impact factor: 91.245

3.  Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.

Authors:  Julius Gudmundsson; Patrick Sulem; Thorunn Rafnar; Jon T Bergthorsson; Andrei Manolescu; Daniel Gudbjartsson; Bjarni A Agnarsson; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Thorarinn Blondal; Margret Jakobsdottir; Simon N Stacey; Jelena Kostic; Kari T Kristinsson; Birgitta Birgisdottir; Shyamali Ghosh; Droplaug N Magnusdottir; Steinunn Thorlacius; Gudmar Thorleifsson; S Lilly Zheng; Jielin Sun; Bao-Li Chang; J Bradford Elmore; Joan P Breyer; Kate M McReynolds; Kevin M Bradley; Brian L Yaspan; Fredrik Wiklund; Par Stattin; Sara Lindström; Hans-Olov Adami; Shannon K McDonnell; Daniel J Schaid; Julie M Cunningham; Liang Wang; James R Cerhan; Jennifer L St Sauver; Sara D Isaacs; Kathleen E Wiley; Alan W Partin; Patrick C Walsh; Sonia Polo; Manuel Ruiz-Echarri; Sebastian Navarrete; Fernando Fuertes; Berta Saez; Javier Godino; Philip C Weijerman; Dorine W Swinkels; Katja K Aben; J Alfred Witjes; Brian K Suarez; Brian T Helfand; Michael L Frigge; Kristleifur Kristjansson; Carole Ober; Eirikur Jonsson; Gudmundur V Einarsson; Jianfeng Xu; Henrik Gronberg; Jeffrey R Smith; Stephen N Thibodeau; William B Isaacs; William J Catalona; Jose I Mayordomo; Lambertus A Kiemeney; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2008-02-10       Impact factor: 38.330

4.  The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.

Authors:  Sari Tuupanen; Mikko Turunen; Rainer Lehtonen; Outi Hallikas; Sakari Vanharanta; Teemu Kivioja; Mikael Björklund; Gonghong Wei; Jian Yan; Iina Niittymäki; Jukka-Pekka Mecklin; Heikki Järvinen; Ari Ristimäki; Mariachiara Di-Bernardo; Phil East; Luis Carvajal-Carmona; Richard S Houlston; Ian Tomlinson; Kimmo Palin; Esko Ukkonen; Auli Karhu; Jussi Taipale; Lauri A Aaltonen
Journal:  Nat Genet       Date:  2009-06-28       Impact factor: 38.330

5.  Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.

Authors:  Brian T Helfand; Angela J Fought; Stacy Loeb; Joshua J Meeks; Donghui Kan; William J Catalona
Journal:  J Urol       Date:  2010-06-17       Impact factor: 7.450

6.  Genetic correction of PSA values using sequence variants associated with PSA levels.

Authors:  Julius Gudmundsson; Soren Besenbacher; Patrick Sulem; Daniel F Gudbjartsson; Isleifur Olafsson; Sturla Arinbjarnarson; Bjarni A Agnarsson; Kristrun R Benediktsdottir; Helgi J Isaksson; Jelena P Kostic; Sigurjon A Gudjonsson; Simon N Stacey; Arnaldur Gylfason; Asgeir Sigurdsson; Hilma Holm; Unnur S Bjornsdottir; Gudmundur I Eyjolfsson; Sebastian Navarrete; Fernando Fuertes; Maria D Garcia-Prats; Eduardo Polo; Ionel A Checherita; Mariana Jinga; Paula Badea; Katja K Aben; Jack A Schalken; Inge M van Oort; Fred C Sweep; Brian T Helfand; Michael Davis; Jenny L Donovan; Freddie C Hamdy; Kristleifur Kristjansson; Jeffrey R Gulcher; Gisli Masson; Augustine Kong; William J Catalona; Jose I Mayordomo; Gudmundur Geirsson; Gudmundur V Einarsson; Rosa B Barkardottir; Eirikur Jonsson; Viorel Jinga; Dana Mates; Lambertus A Kiemeney; David E Neal; Unnur Thorsteinsdottir; Thorunn Rafnar; Kari Stefansson
Journal:  Sci Transl Med       Date:  2010-12-15       Impact factor: 17.956

7.  Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.

Authors:  Julius Gudmundsson; Patrick Sulem; Daniel F Gudbjartsson; Thorarinn Blondal; Arnaldur Gylfason; Bjarni A Agnarsson; Kristrun R Benediktsdottir; Droplaug N Magnusdottir; Gudbjorg Orlygsdottir; Margret Jakobsdottir; Simon N Stacey; Asgeir Sigurdsson; Tiina Wahlfors; Teuvo Tammela; Joan P Breyer; Kate M McReynolds; Kevin M Bradley; Berta Saez; Javier Godino; Sebastian Navarrete; Fernando Fuertes; Laura Murillo; Eduardo Polo; Katja K Aben; Inge M van Oort; Brian K Suarez; Brian T Helfand; Donghui Kan; Carlo Zanon; Michael L Frigge; Kristleifur Kristjansson; Jeffrey R Gulcher; Gudmundur V Einarsson; Eirikur Jonsson; William J Catalona; Jose I Mayordomo; Lambertus A Kiemeney; Jeffrey R Smith; Johanna Schleutker; Rosa B Barkardottir; Augustine Kong; Unnur Thorsteinsdottir; Thorunn Rafnar; Kari Stefansson
Journal:  Nat Genet       Date:  2009-09-20       Impact factor: 38.330

8.  Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations.

Authors:  Jielin Sun; Bao-Li Chang; Sarah D Isaacs; Kathleen E Wiley; Fredrik Wiklund; Pär Stattin; David Duggan; John D Carpten; Bruce J Trock; Alan W Partin; Patrick C Walsh; Henrik Grönberg; Jianfeng Xu; William B Isaacs; S Lilly Zheng
Journal:  Prostate       Date:  2008-09-01       Impact factor: 4.104

9.  Evaluation of the 8q24 prostate cancer risk locus and MYC expression.

Authors:  Mark M Pomerantz; Christine A Beckwith; Meredith M Regan; Stacia K Wyman; Gyorgy Petrovics; Yongmei Chen; Dorota J Hawksworth; Fredrick R Schumacher; Lorelei Mucci; Kathryn L Penney; Meir J Stampfer; Jennifer A Chan; Kristin G Ardlie; Brian R Fritz; Rachael K Parkin; Daniel W Lin; Michelle Dyke; Paula Herman; Steve Lee; William K Oh; Philip W Kantoff; Muneesh Tewari; David G McLeod; Shiv Srivastava; Matthew L Freedman
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

10.  Functional enhancers at the gene-poor 8q24 cancer-linked locus.

Authors:  Li Jia; Gilad Landan; Mark Pomerantz; Rami Jaschek; Paula Herman; David Reich; Chunli Yan; Omar Khalid; Phil Kantoff; William Oh; J Robert Manak; Benjamin P Berman; Brian E Henderson; Baruch Frenkel; Christopher A Haiman; Matthew Freedman; Amos Tanay; Gerhard A Coetzee
Journal:  PLoS Genet       Date:  2009-08-14       Impact factor: 5.917

View more
  5 in total

1.  Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.

Authors:  Brian T Helfand; Kimberly A Roehl; Phillip R Cooper; Barry B McGuire; Liesel M Fitzgerald; Geraldine Cancel-Tassin; Jean-Nicolas Cornu; Scott Bauer; Erin L Van Blarigan; Xin Chen; David Duggan; Elaine A Ostrander; Mary Gwo-Shu; Zuo-Feng Zhang; Shen-Chih Chang; Somee Jeong; Elizabeth T H Fontham; Gary Smith; James L Mohler; Sonja I Berndt; Shannon K McDonnell; Rick Kittles; Benjamin A Rybicki; Matthew Freedman; Philip W Kantoff; Mark Pomerantz; Joan P Breyer; Jeffrey R Smith; Timothy R Rebbeck; Dan Mercola; William B Isaacs; Fredrick Wiklund; Olivier Cussenot; Stephen N Thibodeau; Daniel J Schaid; Lisa Cannon-Albright; Kathleen A Cooney; Stephen J Chanock; Janet L Stanford; June M Chan; John Witte; Jianfeng Xu; Jeannette T Bensen; Jack A Taylor; William J Catalona
Journal:  Hum Genet       Date:  2015-02-26       Impact factor: 4.132

2.  Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival.

Authors:  Jennifer A Freedman; Yanru Wang; Xuechan Li; Hongliang Liu; Patricia G Moorman; Daniel J George; Norman H Lee; Terry Hyslop; Qingyi Wei; Steven R Patierno
Journal:  Carcinogenesis       Date:  2018-07-03       Impact factor: 4.944

3.  The presence of LUTS is not a decisive tool for deciding who should be qualified for prostate biopsy.

Authors:  Kajetan Juszczak
Journal:  Cent European J Urol       Date:  2014

4.  Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma.

Authors:  Tatyana Vagner; Cristiana Spinelli; Valentina R Minciacchi; Leonora Balaj; Mandana Zandian; Andrew Conley; Andries Zijlstra; Michael R Freeman; Francesca Demichelis; Subhajyoti De; Edwin M Posadas; Hisashi Tanaka; Dolores Di Vizio
Journal:  J Extracell Vesicles       Date:  2018-08-07

5.  Correlation Between CASC8, SMAD7 Polymorphisms and the Susceptibility to Colorectal Cancer: An Updated Meta-Analysis Based on GWAS Results.

Authors:  Kunhou Yao; Long Hua; Lunshou Wei; Jiming Meng; Junhong Hu
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.